Total trials
96
Active
18
Phase 3
0
Total enrollment
5,874
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Dexamethasone | — | — | — | — | — | 1 |
Next readouts
- 2026-02-02
Top conditions
- Hearing Loss39
- Hearing Loss, Sensorineural9
- Sensorineural Hearing Loss9
- Hearing Loss, Conductive7
- Conductive Hearing Loss5
- Hearing Loss, Bilateral5
- Mixed Hearing Loss4
- Sensorineural Hearing Loss, Bilateral4
Frequently asked questions about Cochlear
- How many clinical trials does Cochlear have on ClinicalTrials.gov?
- Cochlear is listed as the lead sponsor on 96 clinical trials in ClinicalTrials.gov, 18 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Cochlear's trials are in Phase 3?
- 0 of Cochlear's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does Cochlear focus on?
- Cochlear's most-studied conditions on ClinicalTrials.gov are Hearing Loss, Hearing Loss, Sensorineural, Sensorineural Hearing Loss, Hearing Loss, Conductive, Conductive Hearing Loss.
- When are Cochlear's next clinical trial readouts?
- Cochlear has 1 upcoming primary-completion readout tracked here; the soonest is “Safety and Efficacy of a Drug Eluting Slim Modiolar Electrode Array”, expected around 2026-02-02.